The global bone densitometers market size is expected to reach USD 1.2 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of metabolic bone diseases is believed to be responsible for the high clinical urgency to adopt bone densitometers, thereby impelling the market demand. The growing base of the geriatric and obese population, which is highly susceptible to developing disorders such as osteoporosis, is anticipated to propel the demand further. The aforementioned factors are slated to present the market with lucrative growth opportunities over the coming years.
Moreover, the presence of a consistent number of health initiatives to promote awareness pertaining to osteoporosis is anticipated to broaden market growth potential over the coming years. For instance, National Osteoporosis Foundation (NOF), a government healthcare organization that conducts National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs, is focused on elevating awareness levels pertaining to available diagnostic & treatment alternatives for osteoporosis. It also encourages the training of healthcare professionals for efficient management of osteoporosis.
In addition, the advent of technologically advanced devices, such as portable densitometers, is presumed to fuel their adoption in home healthcare. Other technological advancements include the implementation of advanced hip assessment software into DXA systems that enabled noninvasive assessment of proximal femur structural geometry. Additional associated benefits include the depiction of a wide array of parameters such as skeletal mapping, hip axis length assessment, areal BMD determination, and cross-sectional area & the femoral strength index.
Request a free sample copy or view report summary: Bone Densitometer Market Report
Peripheral bone densitometry is expected to exhibit lucrative CAGR owing to increasing adoption in a wide array of clinical applications. The high penetration can be attributed to efficient peripheral fracture risk assessment, not achievable by other technologies
Clinics are anticipated to exhibit lucrative CAGR during the forecast period owing to the advent of portable densitometers that are increasingly being preferred by clinicians due to associated benefits such as compact size, accuracy, and ease of transportation
In 2016, North America held a dominant share of the global bone densitometer market, as a consequence of increasing localized presence of prominent companies undertaking competitive sustainability strategies
Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgrades, and growing healthcare expenditure
Some key participants implement various competitive strategies, such as new product development & frequent product approvals, to maintain their position in the market
For instance, in October 2016, BeamMed launched neonatal bone growth assessment software for premature babies, which is compatible with most of the densitometer tools
Grand View Research has segmented the global bone densitometers market on the basis of technology, end use, and region:
Bone Densitometers Technology Outlook (Revenue, USD Million, 2014 - 2025)
Axial Bone Densitometry
Dual Energy X-Ray Absorptiometry (DEXA)
Quantitative Computed Tomography (QCT)
Peripheral Bone Densitometry
Single Energy X-Ray Absorptiometry (SEXA)
Dual Energy X-Ray Absorptiometry (PDEXA)
Radiographic Absorptiometry (RA)
Quantitative Ultrasound (QUS)
Peripheral Quantitative Computed Tomography (pQCT)
Bone Densitometers End-Use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Clinics
Bone Densitometers Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
MEA
South Africa
"The quality of research they have done for us has been excellent..."